Androgen insensitivity syndrome CT

Jump to navigation Jump to search

Androgen insensitivity syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Androgen insensitivity syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Androgen insensitivity syndrome CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Androgen insensitivity syndrome CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Androgen insensitivity syndrome CT

CDC on Androgen insensitivity syndrome CT

Androgen insensitivity syndrome CT in the news

Blogs on Androgen insensitivity syndrome CT

Directions to Hospitals Treating Androgen insensitivity syndrome

Risk calculators and risk factors for Androgen insensitivity syndrome CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]

Overview

Findings of seminoma are observed by FDG PET/CT in androgen insensitivity syndrome. Detection of sertoli-Leydig cell tumor accidentally is by FDG-PET/CT imaging.

CT

  • FDG-PET/CT findings are observed of seminoma in androgen insensitivity syndrome.[1]
  • PET images showed focal FDG uptake in the left pelvic sidewall, and a hypodense lesion with calcifications was noted in the corresponding CT images.
  • Another smaller hypodense lesion with calcifications was noted in the right pelvic sidewall, but faint FDG uptake.
  • Detection of sertoli-Leydig cell tumor accidentally is by FDG-PET/CT imaging. An F-18 fluorodeoxyglucose PET study, and a pathologically increased FDG uptake at the left lower abdomen was detected corresponding to a solid, cystic lesion on CT images. [2]

References

  1. Han EJ, O JH, Park G, Lee J (2017). "FDG PET/CT Image of Seminoma in Androgen Insensitivity Syndrome". Clin Nucl Med. 42 (8): e381–e382. doi:10.1097/RLU.0000000000001722. PMID 28604478.
  2. Ozülker T, Ozpaçaci T, Ozülker F, Ozekici U, Bilgiç R, Mert M (2010). "Incidental detection of Sertoli-Leydig cell tumor by FDG PET/CT imaging in a patient with androgen insensitivity syndrome". Ann Nucl Med. 24 (1): 35–9. doi:10.1007/s12149-009-0321-x. PMID 19957213.

Template:WH Template:WS